Miyashita, N.; Nakamori, Y.; Ogata, M.; Fukuda, N.; Yamura, A.; Ishiura, Y.; Nomura, S.
Clinical Differences between Community-Acquired Mycoplasma pneumoniae Pneumonia and COVID-19 Pneumonia. J. Clin. Med. 2022, 11, 964.
https://doi.org/10.3390/jcm11040964
AMA Style
Miyashita N, Nakamori Y, Ogata M, Fukuda N, Yamura A, Ishiura Y, Nomura S.
Clinical Differences between Community-Acquired Mycoplasma pneumoniae Pneumonia and COVID-19 Pneumonia. Journal of Clinical Medicine. 2022; 11(4):964.
https://doi.org/10.3390/jcm11040964
Chicago/Turabian Style
Miyashita, Naoyuki, Yasushi Nakamori, Makoto Ogata, Naoki Fukuda, Akihisa Yamura, Yoshihisa Ishiura, and Shosaku Nomura.
2022. "Clinical Differences between Community-Acquired Mycoplasma pneumoniae Pneumonia and COVID-19 Pneumonia" Journal of Clinical Medicine 11, no. 4: 964.
https://doi.org/10.3390/jcm11040964
APA Style
Miyashita, N., Nakamori, Y., Ogata, M., Fukuda, N., Yamura, A., Ishiura, Y., & Nomura, S.
(2022). Clinical Differences between Community-Acquired Mycoplasma pneumoniae Pneumonia and COVID-19 Pneumonia. Journal of Clinical Medicine, 11(4), 964.
https://doi.org/10.3390/jcm11040964
